Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on May 15, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Flat Panel Detector

Closed
CDRH-2026-123668Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The FDA’s Center for Devices and Radiological Health, through the Office of Acquisition and Grant Services, has issued a Request for Information (RFI) numbered CDRH-2026-133668 to identify vendors capable of supplying a large-area 2D X-ray flat panel detector for use in laboratory CBCT and fluoroscopy systems. This RFI is purely for market research and planning purposes and does not constitute a solicitation, request for proposal, or any obligation to award a contract. Vendors are requested to provide detailed technical specifications confirming compliance with mandatory performance criteria including an active imaging area of at least 42.7 cm × 42.7 cm, modulation transfer function ≥50% at 1 lp/mm, detective quantum efficiency ≥70% at 0 lp/mm, fluoroscopy frame rate ≥25 fps, pixel pitch ≤170 μm, lag ≤3% after one frame, energy range of 40–150 kVp, fill factor ≥60%, air cooling only, operating temperature range of 19–49°C, relative humidity tolerance of 10–90% non-condensing, radiation tolerance of ≥2,000 Gy, weight ≤15 kg, a minimum one-year warranty, and one year of remote technical support. Responses must be submitted via email to Freshta.Javid@fda.hhs.gov by 5:00 PM Eastern Time on May 22, 2026, and are limited to five pages or fewer. The response must include the company name, address, CAGE code, Unique Entity ID, business size classification, estimated pricing, delivery lead time, and any exceptions to the specified requirements. No contract clauses, evaluation factors, award criteria, packaging specifications, or formal delivery terms are included, as this is not a procurement action. The place of performance for any future delivery would be Silver Spring, Maryland, and all information provided will be used solely to assess market capabilities and inform potential future solicitations.

General Info

FDA seeks flat panel detector info under NAICS 334510, response due May 21, Silver Spring.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

334510 - Electromedical and Electrotherapeutic Apparatus ManufacturingView NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

NONE

Documents

(1)

RFI CDRH-2026-133668 Large-Area 2D X-Ray Flat Panel Detector

DOCXrfi

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA

Full Description

Show more

Please refer to the attachment. 

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human induced pluripotent stem cell (iPSC)-derived hindbrain organoid functional assay services. The project aims to support in vitro research evaluating drug-induced effects on respiratory-relevant neural circuits over an eighteen-month period of performance. The scope of work is divided into two primary components: the provision of human hindbrain organoids and associated culture materials through twelve scheduled deliveries to the FDA White Oak Campus, and the performance of functional characterization services at the contractor's laboratory. Functional characterization will utilize three-dimensional multi-electrode array (3D MEA) technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Deliverables include the delivery of 96 organoids in the first shipment followed by 48 organoids in subsequent deliveries, as well as raw data, analyzed data, analysis files, and comprehensive study reports. This acquisition is conducted as a commercial service under FAR Part 12, with the government restricting competition based on market research identifying OrganoTherapeutics SARL as the only source capable of meeting the complete requirement for both the specific organoid products and the associated functional assay services.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 13 hours ago

DEADLINE

in 6 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS